Rare diseases
Investigational molecules
Locations
200 Smith Street, 02451-0099, United States
Deciphera Pharmaceuticals Inc. focuses on advanced gastrointestinal stromal tumor (GIST), including patients with prior imatinib treatment, and related malignant solid tumors. Its clinical research also extends to metastatic solid tumor settings and broader advanced tumor populations.
The sponsor’s portfolio includes studies in KIT-mutant disease and other solid tumor contexts where targeted treatment options remain limited.
Deciphera Pharmaceuticals Inc. runs clinical trials in conditions such as Gastrointestinal stromal tumour, Polycythaemia vera, Central nervous system lymphoma, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
AustriaStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
AustriaStudy of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)
DenmarkStudy of DCC-3084 alone and with other cancer drugs in patients with advanced solid tumors driven by the MAPK pathway
FranceStudy Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib
FranceStudy on Vimseltinib for Patients with Tenosynovial Giant Cell Tumor
FranceStudy on the Safety and Effects of Vimseltinib for Patients with Advanced Tumors and Tenosynovial Giant Cell Tumor
FranceStudy of DCC-3116 with Sotorasib, Binimetinib, and Trametinib for Patients with Advanced or Metastatic Solid Tumors with RAS/MAPK Pathway Mutations
FranceStudy of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
